Bone Marrow TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, HomologousBone MarrowTransplantation, AutologousHematopoietic Stem Cell TransplantationBone Marrow CellsGraft vs Host DiseaseTransplantation ConditioningHematopoietic Stem Cell MobilizationWhole-Body IrradiationHematopoietic Stem CellsGranulocyte Colony-Stimulating FactorGraft SurvivalBusulfanAnemia, AplasticCyclophosphamideTransplantation ChimeraBone and BonesLeukemiaTissue DonorsLeukapheresisHematologic NeoplasmsCombined Modality TherapyBone Marrow PurgingAntigens, CD34Histocompatibility TestingHistocompatibilityLiver TransplantationHematopoiesisRecurrenceBlood Component RemovalTransplantation, IsogeneicTreatment OutcomeBone Marrow DiseasesStem CellsMelphalanStem Cell TransplantationLymphoma, Non-HodgkinRemission InductionAntineoplastic Combined Chemotherapy ProtocolsLeukemia, Myeloid, AcuteImmunosuppressive AgentsTime FactorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBlood CellsMultiple MyelomaT-LymphocytesKidney TransplantationMice, Inbred C57BLEtoposideLymphocyte DepletionPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukocyte TransfusionBlood Cell CountCord Blood Stem Cell TransplantationColony-Forming Units AssayRetrospective StudiesTransplantation ImmunologyLeukemia, MyeloidRadiation ChimeraAcute DiseaseSurvival AnalysisLeukocyte CountImmunosuppressionFlow CytometryBone Marrow ExaminationMyelodysplastic SyndromesCytarabineHLA AntigensHematologic DiseasesGraft RejectionHepatic Veno-Occlusive DiseaseDisease-Free SurvivalSurvival RateCyclosporineLeukocytes, MononuclearBone RemodelingCarmustineCells, CulturedImmunophenotypingBone Marrow NeoplasmsNuclear FamilyLymphocyte TransfusionInfectionLymphomaCytomegalovirus InfectionsGraft vs Host ReactionFollow-Up StudiesHodgkin DiseaseCell SeparationThiotepaChimeraMyeloablative AgonistsGraft vs Leukemia EffectPlatelet CountHeart TransplantationGraft vs Tumor EffectAntineoplastic Agents, AlkylatingCell Differentiation